KOREA PHARMA Co., Ltd. (KOSDAQ: 032300)

KOREA PHARMA Revenue

KOREA PHARMA had revenue of 19.83B KRW in the quarter ending June 30, 2024, a decrease of -12.12%. This brings the company's revenue in the last twelve months to 80.40B, down -5.59% year-over-year. In the year 2023, KOREA PHARMA had annual revenue of 83.24B with 2.73% growth.

• Revenue (ttm): 80.40B
• Revenue Growth: -5.59%
• P/S Ratio: 2.20
• Revenue / Employee: 600.02M
• Employees: 134
• Market Cap: 177.78B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	83.24B	2.21B	2.73%
Dec 31, 2022	81.03B	1.45B	1.83%
Dec 31, 2021	79.58B	8.07B	11.28%
Dec 31, 2020	71.51B	5.37B	8.12%
Dec 31, 2019	66.14B	5.65B	9.34%